Nephrology
IgAN
Expert Roundtables Podcast: Overall Impact of IgA Nephropathy on Quality of Life
IgA nephropathy (IgAN), the most common glomerular disease in the world, can significantly impact a patient’s daily activities, work, and relationships. In addition to causing physical symptoms, IgAN can also have a substantial negative psychological impact on both patients and their caregivers. Our featured nephrology experts review the impact of IgAN on patient quality of life.
Aldhouse NVJ, Kitchen H, Al-Zubeidi T, et al. Development of a conceptual model for the patient experience of immunoglobulin A nephropathy (IgAN): a qualitative literature review. Adv Ther. 2024;41(4):1325-1337. doi:10.1007/s12325-024-02793-1
Jhaveri KD, Bensink ME, Bunke M, Briggs JA, Cork DMW, Jeyabalan A. Humanistic and economic burden of IgA nephropathy: systematic literature reviews and narrative synthesis. Pharmacoecon Open. 2023;7(5):709-722. doi:10.1007/s41669-023-00415-0
Kwon CS, Daniele P, Forsythe A, Ngai C. A systematic literature review of the epidemiology, health-related quality of life impact, and economic burden of immunoglobulin A nephropathy. J Health Econ Outcomes Res. 2021;8(2):36-45. doi:10.36469/001c.26129
Murphy SL, Mahan JD, Troost JP, et al; CureGN Consortium. Longitudinal changes in health-related quality of life in primary glomerular disease: results from the CureGN study. Kidney Int Rep. 2020;5(10):1679-1689. doi:10.1016/j.ekir.2020.06.041
Yang N, Tang J, Li X, et al. A patient report scale research to access the symptom burden in patients with IgA nephropathy. Sci Rep. 2024;14(1):22104. doi:10.1038/s41598-024-59586-3
Zaidi O, Du F, Tang Z, Bhattacharjee S, Pareja K. Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries. BMC Nephrol. 2024;25(1):136. doi:10.1186/s12882-024-03555-5
